Skin cancer in patients with non-Hodgkin’s lymphoma

References

• Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin’s lymphoma and skin cancer. BMJ310, 1491–1495 (1995).
   PubMed Web of Science ®Google Scholar
• Chuang MW, Tzeng CH, Liu JH et al. [Second primary cancer in hematological malignancy experience in VGH-Taipei]. Zhonghua. Yi. Xue. Za. Zhi. (Taipei)44, 325–330 (1989).
   Google Scholar
• Dasanu CA, Alexandrescu DT. Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. MedGenMed9, 35 (2007).
   PubMedGoogle Scholar
• Greene MH, Hoover RN, Fraumeni JF Jr. Subsequent cancer in patients with chronic lymphocytic leukaemia – a possible immunologic mechanism. J. Natl Cancer Inst.61, 337–340 (1978).
   PubMed Web of Science ®Google Scholar
• Landgren O, Pfeiffer RM, Stewart L et al. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int. J. Cancer120, 1099–1102 (2007).
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin’s lymphomas, chronic lymphocytic leukaemias and skin cancers. Br. J. Cancer74, 1847–1850 (1996).
   PubMed Web of Science ®Google Scholar
• Lowsky R, Lipton J, Fyles G et al. Secondary malignancies after bone marrow transplantation in adults. J. Clin. Oncol.12, 2187–2192 (1994).
   PubMed Web of Science ®Google Scholar
• Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA232, 267–269 (1975).
   PubMed Web of Science ®Google Scholar
• Osterlind A, Olsen JH, Lynge E, Ewertz M. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943–80. Natl Cancer Inst. Monogr.68, 361–388 (1985).
   PubMedGoogle Scholar
• Quaglino D, Di Leonardo G, Lalli G et al. Association between chronic lymphocytic leukaemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkell cell) carcinoma. Eur. Rev. Med. Pharmacol. Sci.1, 11–16 (1997).
   PubMedGoogle Scholar
• Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J. Natl Cancer Inst.84, 1422–1427 (1992).
   PubMed Web of Science ®Google Scholar
• Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr. Treat. Options Oncol.5, 215–223 (2004).
   PubMedGoogle Scholar
• Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB. Cutaneous findings in chronic lymphocytic leukaemia. Br. J. Dermatol.150, 1129–1135 (2004).
   PubMed Web of Science ®Google Scholar
• Mellemgaard A, Geisler CH, Storm HH. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur. J. Haematol.53, 218–222 (1994).
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943–1989. Int. J. Cancer61, 773–779 (1995).
   PubMed Web of Science ®Google Scholar
• Ben-David A, Lazarov A, Lev S, Nussbaum B. Merkel cell tumor and chronic lymphocytic leukemia – coincidence or a possible association? Dermatol. Online J.11, 16 (2005).
   Google Scholar
• Carroll P, Goldstein GD, Brown CW Jr. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol. Surg.26, 531–534 (2000).
   PubMed Web of Science ®Google Scholar
• Cervigon I, Gargallo AB, Bahillo C et al. [Merkel cell carcinoma in a patient with chronic lymphocytic leukemia]. Acta Dermosifiliogr.97, 264–266 (2006).
   Google Scholar
• Cottoni F, Masia IM, Cossu S, Montesu MA, Pardini S, Massarelli G. Classical Kaposi’s sarcoma and chronic lymphocytic leukaemia in the same skin biopsy. Report of two cases. Br. J. Dermatol.139, 753–754 (1998).
   Google Scholar
• Hull PR, Saxena A. Mycosis fungoides and chronic lymphocytic leukaemia – composite T-cell and B-cell lymphomas presenting in the skin. Br. J. Dermatol.143, 439–444 (2000).
   PubMed Web of Science ®Google Scholar
• Kemp JD, Stenn KS, Arons M, Fischer J. Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia. Arch. Dermatol.114, 1533–1535 (1978).
   Google Scholar
• Suss A, Wetzig T, Sticherling M, Tannapfel A, Simon JC. [Mycosis fungoides and B-cell chronic lymphocytic leukemia: an extremely rare coincidence]. Hautarzt57, 888–892 (2006).
   Google Scholar
• Vergani R, Betti R, Uziel L, Tolomio E, Crosti C. Eruptive multiple sporadic cutaneous piloleiomyomas in a patient with chronic lymphocytic leukaemia. Br. J. Dermatol.143, 907–909 (2000).
   Google Scholar
• Vlad R, Woodlock TJ. Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. Am. J. Clin. Oncol.26, 531–534 (2003).
   PubMed Web of Science ®Google Scholar
• Warakaulle DR, Rytina E, Burrows NP. Merkel cell tumour associated with chronic lymphocytic leukaemia. Br. J. Dermatol.144, 216–217 (2001).
   Google Scholar
• McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br. J. Cancer88, 74–78 (2003).
   PubMed Web of Science ®Google Scholar
• Koh HK. Cutaneous melanoma. N. Engl. J. Med.325, 171–182 (1991).
   PubMed Web of Science ®Google Scholar
• Otley CC. Non-Hodgkin lymphoma and skin cancer: a dangerous combination. Australas. J. Dermatol.47, 231–236 (2006).
   PubMed Web of Science ®Google Scholar
• Berg JW. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J. Natl Cancer Inst.38, 741–752 (1967).
   PubMed Web of Science ®Google Scholar
• Albregts T, Orengo I, Salasche S, Duncan L, Sillman J, Hassoun H. Squamous cell carcinoma in a patient with chronic lymphocytic leukemia. An intraoperative diagnostic challenge for the Mohs surgeon. Dermatol. Surg.24, 269–272 (1998).
   Google Scholar
• Fowler JF Jr, Knuckles ML. Multiple cutaneous squamous cell carcinomas in a patient with chronic lymphocytic leukemia. Cutis36, 467–469 (1985).
   Google Scholar
• Karsai S, Hou JS, Telang G, Kantor GR, Nowell PC, Vonderheid EC. Sezary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature. Dermatology216, 68–75 (2008).
   PubMed Web of Science ®Google Scholar
• Koljonen V, Kukko H, Pukkala E et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br. J. Cancer101, 1444–1447 (2009).
   PubMed Web of Science ®Google Scholar
• Konstantopoulos K, Kapsimalis V, Vaiopoulos G et al. Simultaneous appearance of mycosis fungoides and chronic lymphocytic leukemia in the same patient. Haematologia (Budap.)30, 41–43 (2000).
   Google Scholar
• McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br. J. Dermatol.143, 171–173 (2000).
   PubMed Web of Science ®Google Scholar
• Moayeri H, Han T, Stutzman L, Sokal JE. Second neoplasms with chronic lymphocytic leukemia. NY State J. Med.76, 378–381 (1976).
   PubMedGoogle Scholar
• Pizarro A, Baron JM. Kaposi’s sarcoma and lymphoid neoplasia in the same lesion. Arch. Pathol. Lab. Med.116, 812–813 (1992).
   Google Scholar
• Ramsay HM, Fryer A, Strange RC, Smith AG. Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia. Clin. Exp. Dermatol.24, 281–282 (1999).
   Google Scholar
• Safadi R, Pappo O, Okon E, Sviri S, Eldor A. Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk. Lymphoma20, 509–511 (1996).
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Wen S, McLaughlin P et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J. Clin. Oncol.27, 904–910 (2009).
   PubMed Web of Science ®Google Scholar
• Ziprin P, Smith S, Salerno G, Rosin RD. Two cases of merkel cell tumour arising in patients with chronic lymphocytic leukaemia. Br. J. Dermatol.142, 525–528 (2000).
   PubMed Web of Science ®Google Scholar
• Liegl B, Leibl S, Okcu M, Beham-Schmid C, Regauer S. Malignant transformation within benign adnexal skin tumours. Histopathology45, 162–170 (2004).
   Google Scholar
• Davidovitz Y, Ballin A, Meytes D. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Acta Haematol.98, 44–46 (1997).
   PubMed Web of Science ®Google Scholar
• Robak E, Biernat W, Krykowski E, Jeziorski A, Robak T. Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab. Leuk. Lymphoma46, 909–914 (2005).
   PubMed Web of Science ®Google Scholar
• Adami J, Gridley G, Nyren O et al. Sunlight and non-Hodgkin’s lymphoma: a population-based cohort study in Sweden. Int. J. Cancer80, 641–645 (1999).
   PubMed Web of Science ®Google Scholar
• Smedby KE, Hjalgrim H, Melbye M et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl Cancer Inst.97, 199–209 (2005).
   PubMed Web of Science ®Google Scholar
• Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol.30, 774–778 (1994).
   PubMed Web of Science ®Google Scholar
• Mikhail GR. Metastatic basal cell carcinoma. J. Dermatol. Surg. Oncol.12, 507–509 (1986).
   Google Scholar
• Mikhail GR, Nims LP, Kelly AP Jr. Ditmars DM Jr, Eyler WR. Metastatic basal cell carcinoma: review, pathogenesis, and report of two cases. Arch. Dermatol.113, 1261–1269 (1977).
   PubMed Web of Science ®Google Scholar
• von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J. Am. Acad. Dermatol.10, 1043–1060 (1984).
   PubMed Web of Science ®Google Scholar
• Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977–1978 and 1998–1999 in Northcentral New Mexico. Cancer Epidemiol. Biomarkers Prev.12, 1105–1108 (2003).
   PubMedGoogle Scholar
• Brewer JD, Colegio OR, Phillips PK et al. Incidence of and risk factors for skin cancer after heart transplant. Arch. Dermatol.145, 1391–1396 (2009).
   PubMed Web of Science ®Google Scholar
• Lanoy E, Costagliola D, Engels EA. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int. J. Cancer126, 1724–1731 (2010).
   PubMed Web of Science ®Google Scholar
• Mackenzie KA, Wells JE, Lynn KL et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol. Dial. Transplant.25, 300–306 (2010).
   Google Scholar
• Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr. Treat. Options Oncol.3, 193–203 (2002).
   PubMedGoogle Scholar
• Nelson BR, Railan D, Cohen S. Mohs’ micrographic surgery for nonmelanoma skin cancers. Clin. Plast. Surg.24, 705–718 (1997).
   Google Scholar
• Hruza GJ. Mohs micrographic surgery local recurrences. J. Dermatol. Surg. Oncol.20, 573–577 (1994).
   Google Scholar
• Lawrence CM. Mohs surgery of basal cell carcinoma – a critical review. Br. J. Plast. Surg.46, 599–606 (1993).
   PubMedGoogle Scholar
• Miller PK, Roenigk RK, Brodland DG, Randle HW. Cutaneous micrographic surgery: Mohs procedure. Mayo Clin. Proc.67, 971–980 (1992).
   Google Scholar
• Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia. Arch. Dermatol.140, 985–988 (2004).
   PubMed Web of Science ®Google Scholar
• Geller AC, Annas GD. Epidemiology of melanoma and nonmelanoma skin cancer. Semin. Oncol. Nurs.19, 2–11 (2003).
   PubMedGoogle Scholar
• Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer – the role of sunlight. Adv. Exp. Med. Biol.624, 89–103 (2008).
   PubMed Web of Science ®Google Scholar
• Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin. Proc.76, 1253–1265 (2001).
   PubMed Web of Science ®Google Scholar
• Darmstadt GL, Steinman HK. Mohs’ micrographic surgery of the head and neck. West. J. Med.152, 153–158 (1990).
   Google Scholar
• Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of squamous cell carcinoma after Mohs’ surgery in patients with chronic lymphocytic leukemia. Dermatol. Surg.31, 38–42; discussion 42 (2005).
   PubMed Web of Science ®Google Scholar
• Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J. Am. Acad. Dermatol.53, 1067–1071 (2005).
   PubMed Web of Science ®Google Scholar
• Hu S, Federman DG, Ma F, Kirsner RS. Skin cancer and non-Hodgkin’s lymphoma: examining the link. Dermatol. Surg.31, 76–82 (2005).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA. Cancer J. Clin.59, 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer77, 1303–1310 (1996).
   PubMed Web of Science ®Google Scholar
• Halliday GM, Patel A, Hunt MJ, Tefany FJ, Barnetson RS. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J. Surg.19, 352–358 (1995).
   PubMed Web of Science ®Google Scholar
• Marshall JA, Forster TH, Purdie DM et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol. Cell. Biol.84, 295–302 (2006).
   PubMed Web of Science ®Google Scholar
• Menzies SW, McCarthy WH. Complete regression of primary cutaneous malignant melanoma. Arch. Surg.132, 553–556 (1997).
   PubMedGoogle Scholar
• Brewer JD, Christenson LJ, Weenig RH, Weaver AL. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Dermatol. Surg.36(3), 368–376 (2010).
   PubMed Web of Science ®Google Scholar
• Kaplan AL, Cook JL. Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Skinmed4, 300–304 (2005).
   Google Scholar
• Askling J, Sorensen P, Ekbom A et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann. Intern. Med.131, 655–659 (1999).
   Google Scholar
• Hjalgrim H, Frisch M, Storm HH, Glimelius B, Pedersen JB, Melbye M. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin’s lymphoma. Int. J. Cancer85, 639–642 (2000).
   PubMed Web of Science ®Google Scholar
• Levine PH, Hoover R. The emerging epidemic of non-Hodgkin’s lymphoma: current knowledge regarding etiological factors. Cancer Epidemiol. Biomarkers Prev.1, 515–517 (1992).
   Google Scholar
• Aslakson CJ, Lee G, Boomer JS, Gilman-Sachs A, Kucuk O, Beaman KD. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. Am. J. Hematol.61, 46–52 (1999).
   PubMed Web of Science ®Google Scholar
• Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat. Med.3, 984–989 (1997).
   PubMed Web of Science ®Google Scholar
• Lacombe C, Gombert J, Dreyfus B, Brizard A, Preud’homme JL. Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia. Clin Immunol.90, 128–132 (1999).
   PubMed Web of Science ®Google Scholar
• Kipps TJ. Genetics of chronic lymphocytic leukaemia. Hematol. Cell. Ther.42, 5–14 (2000).
   Google Scholar
• Kipps TJ. Chronic lymphocytic leukemia. Curr. Opin. Hematol.7, 223–234 (2000).
   PubMed Web of Science ®Google Scholar
• Brewer JD, Christenson LJ, Weenig RH, Weaver AL. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Dermatol. Surg.36, 368–376 (2010).
   PubMed Web of Science ®Google Scholar
• Rashid K, Ng R, Mastan A, Sager D, Hirschman R. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia. Leuk. Lymphoma46, 1051–1055 (2005).
   PubMed Web of Science ®Google Scholar
• Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk. Lymphoma46, 49–54 (2005).
   PubMed Web of Science ®Google Scholar
• Mehrany K, Byrd DR, Roenigk RK et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol. Surg.29, 129–134 (2003).
   PubMed Web of Science ®Google Scholar
• Morrison VA, Rai KR, Peterson BL et al. Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J. Clin. Oncol.19, 3611–3621 (2001).
   PubMed Web of Science ®Google Scholar
• Schlaifer D, Riga-Huguet F, Pris J, Brousset P, Delannoy A, Bosly A. Secondary neoplasms in two patients treated with purine analogues. Nouv. Rev. Fr. Hematol.36, 341 (1994).
   PubMedGoogle Scholar
• Shimm DS, Wilder RB. Radiation therapy for squamous cell carcinoma of the skin. Am. J. Clin. Oncol.14, 383–386 (1991).
   Google Scholar
• Wagner JD, Evdokimow DZ, Weisberger E et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch. Dermatol.140, 75–79 (2004).
   PubMedGoogle Scholar
• Black HS, Herd JA, Goldberg LH et al. Effect of a low-fat diet on the incidence of actinic keratosis. N. Engl. J. Med.330, 1272–1275 (1994).
   PubMed Web of Science ®Google Scholar
• Black HS, Okotie-Eboh G, Gerguis J. Immunobiology of lipid-modulated UV-carcinogenesis. J. Photochem. Photobiol. B.44, 124–129 (1998).
   Google Scholar
• Berwick M, Kesler D. Ultraviolet radiation exposure, vitamin D, and cancer. Photochem. Photobiol.81, 1261–1266 (2005).
   PubMed Web of Science ®Google Scholar
• De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol. Surg.30, 656–661 (2004).
   PubMed Web of Science ®Google Scholar
• DiGiovanna JJ. Systemic retinoid therapy. Dermatol. Clin.19, 161–167 (2001).
   PubMed Web of Science ®Google Scholar
• DiGiovanna JJ. Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention. Transplant. Proc.30, 2771–2775; discussion 2776–2778 (1998).
   Google Scholar
• DiGiovanna JJ. Retinoid chemoprevention in the high-risk patient. J. Am. Acad. Dermatol.39, S82–S85 (1998).
   Google Scholar
• Bolshakov S, Walker CM, Strom SS et al.p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin. Cancer Res.9, 228–234 (2003).
   Google Scholar
• Gailani MR, Leffell DJ, Ziegler A, Gross EG, Brash DE, Bale AE. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J. Natl Cancer Inst.88, 349–354 (1996).
   PubMedGoogle Scholar
• Rady P, Scinicariello F, Wagner RF Jr. Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res.52, 3804–3806 (1992).
   PubMedGoogle Scholar
• Ziegler A, Leffell DJ, Kunala S et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA90, 4216–4220 (1993).
   PubMed Web of Science ®Google Scholar
• Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA88, 10124–10128 (1991).
   PubMed Web of Science ®Google Scholar
• Nataraj AJ, Trent JC 2nd, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem. Photobiol.62, 218–230 (1995).
   PubMed Web of Science ®Google Scholar
• Nelson MA, Einspahr JG, Alberts DS et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett.85, 23–29 (1994).
   PubMed Web of Science ®Google Scholar
• Campbell C, Quinn AG, Ro YS, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J. Invest. Dermatol.100, 746–748 (1993).
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Benner A et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med.343, 1910–1916 (2000).
   PubMed Web of Science ®Google Scholar
• Coll-Mulet L, Gil J. Genetic alterations in chronic lymphocytic leukaemia. Clin. Transl. Oncol.11, 194–198 (2009).
   PubMed Web of Science ®Google Scholar
• Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood82, 1820–1828 (1993).
   PubMed Web of Science ®Google Scholar
• Papakonstantinou G, Verbeke C, Hastka J, Bohrer M, Hehlmann R. bcl-2 expression in non-Hodgkin’s lymphomas is not associated with bcl-2 gene rearrangements. Br. J. Haematol.113, 383–390 (2001).
   PubMed Web of Science ®Google Scholar
• Thomadaki H, Scorilas A. BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci.43, 1–67 (2006).
   PubMed Web of Science ®Google Scholar
• Mikhail M, Velazquez E, Shapiro R et al.PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation. Clin Cancer Res.11, 5153–5157 (2005).
   PubMed Web of Science ®Google Scholar
• Hamai A, Richon C, Meslin F et al. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation. Oncogene25, 7618–7634 (2006).
   PubMed Web of Science ®Google Scholar